REACTIVE CHANGES IN COMPLETE BLOOD COUNT AND BASIC TREATMENTOF IRON DEFICIENCY ANEMIA
Abstract
BACKGROUND Iron deficiency anemia is the most frequently encountered type of anemia and is often thecause of visit to the outpatient clinic. Besides the expected changes in complete blood count,we were interested in reactive thrombocytosis and leucopenia in analyzed patients. METHODS We retrospectively analyzed 35 patients diagnosed with microcytic anemia, that were sentto our outpatient clinic in the period of 21 months. The average age was 41 years, rangingfrom 21 to 74 years. There were 34 females and one male in the group. We only includedpatients with initial and follow-up laboratory test results that included complete bloodcount, serum iron, ferritin levels, and total iron binding capacity (TIBC). RESULTS After oral iron replacement therapy, the blood hemoglobin levels and serum ferritin levelsreturned to the normal range in all our patients. Initially, thrombocytosis was present in20/35 patients and persisted only in 4 after successful treatment. There was only one caseof initial leucopenia that was corrected with iron deficiency anemia correction. CONCLUSIONS Iron deficiency anemia is often accompanied by reactive thrombocytosis and not so oftenby leucopenia. In most cases they are transient if the treatment of iron deficiency anemia issuccessfulDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
